| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2011 | US7998995 LXR and FXR modulators |
| 08/16/2011 | US7998994 Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 08/16/2011 | US7998993 TRPV1 antagonists |
| 08/16/2011 | US7998992 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1 |
| 08/16/2011 | US7998991 Neurotherapeutic treatment for sexual dysfunction |
| 08/16/2011 | US7998990 5-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors |
| 08/16/2011 | US7998989 2-Imino-1,3-thiazoline-based compounds and T-type calcium channel inhibitors containing the same |
| 08/16/2011 | US7998987 Inhibitors of c-Met and uses thereof |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998985 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator |
| 08/16/2011 | US7998984 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 08/16/2011 | US7998983 Substituted isoxazoles as fungicides |
| 08/16/2011 | US7998982 Amide derivatives as TRPV1 antagonists |
| 08/16/2011 | US7998981 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
| 08/16/2011 | US7998980 Compounds for modulating TRPV3 function |
| 08/16/2011 | US7998979 Antibacterial quinoline derivatives |
| 08/16/2011 | US7998978 Substituted 2-amino-fused heterocyclic compounds |
| 08/16/2011 | US7998977 Inhibitors of AKT (protein kinase B) |
| 08/16/2011 | US7998976 Certain chemical entities, compositions and methods |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998974 Fused heterocyclic compounds and their use as sirtuin modulators |
| 08/16/2011 | US7998973 Tivozanib and temsirolimus in combination |
| 08/16/2011 | US7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2011 | US7998971 Combinations containing a 4-acylaminopyridine derivative |
| 08/16/2011 | US7998970 Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders |
| 08/16/2011 | US7998969 Non-nucleoside reverse transcriptase inhibitors |
| 08/16/2011 | US7998968 Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
| 08/16/2011 | US7998967 Methotrexate adjuvants to reduce toxicity and methods for using the same |
| 08/16/2011 | US7998966 Axl kinase inhibitors |
| 08/16/2011 | US7998965 Glutamate aggrecanase inhibitors |
| 08/16/2011 | US7998964 hydroxy((2S)-2-{[4-(4-methoxyphenyl)piperazin-1-yl]carbonyl}-4-methylpentyl)formamide ; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative disorders, stroke, cancer, pre-term labor, endometriosis |
| 08/16/2011 | US7998963 Arylpiperazine derivatives and uses thereof |
| 08/16/2011 | US7998962 Enantiomers of 2'-Fluoralky1-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics |
| 08/16/2011 | US7998961 For treating conditions associated with UDP-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) |
| 08/16/2011 | US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 08/16/2011 | US7998958 Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 08/16/2011 | US7998957 Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use |
| 08/16/2011 | US7998956 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/16/2011 | US7998954 Pyrimidodiazepinone derivative |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998952 Thiolactams and uses thereof |
| 08/16/2011 | US7998951 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid |
| 08/16/2011 | US7998950 Antiviral compounds |
| 08/16/2011 | US7998949 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
| 08/16/2011 | US7998948 Pharmaceutical composition for treating esophageal cancer |
| 08/16/2011 | US7998947 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998945 Methods for the treatment and amelioration of atopic dermatitis |
| 08/16/2011 | US7998944 Polymerizable compound and use thereof |
| 08/16/2011 | US7998943 Treating a subject in need of therapy for a condition involving detrimental activity of the enzyme Core 2 GlcNAc-T(Core 2-N-acetylglucosaminyl transferase) comprising administration of a steroid compound inhibitor thereof; multiple sclerosis; antiinflammatory, anticarcinogenic agents |
| 08/16/2011 | US7998942 Eye drop preparation comprising xanthan gum and terpenoid |
| 08/16/2011 | US7998941 Hypoxia inducible VEGF plasmid for ischemic disease |
| 08/16/2011 | US7998937 Flavonoid compound having an antiviral activity |
| 08/16/2011 | US7998936 Use of timosaponin Bll in the preparation of a medicament or product for the prevention and treatment of stroke |
| 08/16/2011 | US7998935 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 08/16/2011 | US7998925 Spatially-defined modification of fresh tissue using covalent chemistry |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998740 Cytokine induction of selectin ligands on cells |
| 08/16/2011 | US7998739 Methods of activating NKT cells |
| 08/16/2011 | US7998698 Method for predicting susceptibility to radiation pneumonitis |
| 08/16/2011 | US7998541 Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 08/16/2011 | US7998510 Low dose colonic cleansing system |
| 08/16/2011 | US7998507 Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors |
| 08/16/2011 | US7998506 Dosing a hyperlipidemic with an effective anticholesterol amount of nicotinic acid once per day in the evening or at night; combined with a pharmaceutically acceptable carrier to form an oral solid dosage form; side effect reduction |
| 08/16/2011 | US7998503 Form of administration for controlling primary headaches |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
| 08/16/2011 | US7998467 Preferably 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid dispersed in a polyurethane comprised of 4-4'-diamino dicyclohexylmethane and ethylene glycol or 1,2-propylene glycol; acne, rosacea; sunscreen agents; aging resistance; bioavailability |
| 08/16/2011 | US7998466 Biocompatible tissue sealants and adhesives |
| 08/16/2011 | US7998462 Linkers for anchoring targeting ligands |
| 08/16/2011 | US7998460 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 08/16/2011 | CA2646209C Use of strobilurins for treating malfunctions of the iron metabolism |
| 08/16/2011 | CA2636985C Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/16/2011 | CA2635262C 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 08/16/2011 | CA2629777C Spirocyclic compounds as hdac inhibitors |
| 08/16/2011 | CA2626679C Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
| 08/16/2011 | CA2624749C Pyrimidine amide compounds as pgds inhibitors |
| 08/16/2011 | CA2614603C Azolo triazines and pyrimidines |
| 08/16/2011 | CA2611566C 2-(1h-indolylsulfanyl)-aryl amine derivatives |
| 08/16/2011 | CA2590261C Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions |
| 08/16/2011 | CA2565993C Salt of 4-or 5- aminosalicylic acid |
| 08/16/2011 | CA2558024C Pet food compositions containing an added boron source |
| 08/16/2011 | CA2557163C Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 08/16/2011 | CA2556653C Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 08/16/2011 | CA2499593C Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 08/16/2011 | CA2496731C Novel benzonaphthyridines |
| 08/16/2011 | CA2493423C Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
| 08/16/2011 | CA2493041C Injectable pharmaceutical composition for treating post-operative joint pain comprising an amide local anesthetic |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2485903C Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/16/2011 | CA2480275C Statin therapy for enhancing cognitive maintenance |
| 08/16/2011 | CA2472880C Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |
| 08/16/2011 | CA2467773C Acyloxymethyl esters of c4-16 n-alkane-dicarboxylic acids for the treatment of acne and other related skin disorders |
| 08/16/2011 | CA2464770C Compound |
| 08/16/2011 | CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 08/16/2011 | CA2450660C Lactone formulations and method of use |
| 08/16/2011 | CA2449002C Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin |